- ARMP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Armata Pharmaceuticals (ARMP) S-3Shelf registration
Filed: 28 Apr 16, 12:00am
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-3) and related Prospectus of AmpliPhi Biosciences Corporation for the registration of up to $75,000,000 in aggregate principal amount of AmpliPhi Biosciences Corporation's common stock, warrants and/or units and to the incorporation by reference therein of our report dated March 30, 2016, with respect to the consolidated financial statements of AmpliPhi Biosciences Corporation, included in its Annual Report (Form 10-K) for the year ended December 31, 2015, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Richmond, Virginia
April 28, 2016
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.